Erlotinib Hydrochloride Tablets Dawb ntsiav tshuaj
Lub npe tshuaj: Erlotinib Hydrochloride Tablets Dawb ntsiav tshuaj
Cov khoom xyaw: Erlotinib Hydrochloride
Cov mis mos molecular: --
Indications: 1. Erlotinib monotherapy yog qhia rau hauv zos advanced los yog metastatic non-small cell ntsws cancer (NSCLC) tom qab tsis ua hauj lwm ntawm tsawg kawg yog ib tug kws khomob regimen yav dhau los. 2. Nyob rau hauv ob lub multicenter, randomized, placebo-tswj theem III kev sim, cov txiaj ntsig tau pom tias erlotinib ua ke nrog platinum-muaj cov tshuaj khomob (carboplatin + paclitaxel; lossis gemcitabine + cisplatin) raws li kev kho thawj kab rau cov neeg mob uas muaj cov kab mob metastatic NSCLC. , uas tsis nce cov txiaj ntsig kho mob piv nrog platinum-muaj tshuaj kho mob ib leeg, thiab yog li tsis pom zoo rau kev kho thawj kab hauv cov mob no. 3. Erlotinib monotherapy tuaj yeem siv rau kev kho mob rau cov neeg mob uas muaj mob hauv zos lossis metastatic uas tsis yog mob qog noj ntshav me me uas nyob ruaj khov tom qab 4 lub voj voog ntawm platinum-raws li thawj-kab kws khomob.
Specification: 100mg
Lub neej txee: 36 hli
Cim npe nrov: Tuam Tshoj erlotinib hydrochloride ntsiav tshuaj dawb, Tuam Tshoj erlotinib hydrochloride ntsiav tshuaj dawb lwm tus neeg
